Citations

Showing 10 of 107966 citations.

Myeloproliferative Transition
SILVERSTEIN, M. N.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 72 | Issue: 4 | Pages: 600-600

10.7326/0003-4819-72-4-600 Get It

Standardization of the Oral Glucose-Tolerance Test
Gastineau, Clifford F.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 71 | Issue: 5_Part_1 | Pages: 1023-1024

10.7326/0003-4819-71-5-1023 | PMID 5360303 Get It

HARMFUL EFFECT OF JOGGING
Hunder, Gene G.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 71 | Issue: 3 | Pages: 664-665

10.7326/0003-4819-71-3-664 | PMID 5809694 Get It

Computers in Medicine
Mayne, John G.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 70 | Issue: 3 | Pages: 641-642

10.7326/0003-4819-70-3-641 | PMID 5775041 Get It

MORE PROBLEMS IN BIOMEDICAL MORES
Millikan, Clark H.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 67 | Issue: 3_Part_1 | Pages: 678-678

10.7326/0003-4819-67-3-678 Get It

AN ERROR AND AN APOLOGY
Dyck, P. James. B., Dyck, P. James B.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 66 | Issue: 5 | Pages: 1025-1025

10.7326/0003-4819-66-5-1025 Get It

Tetanus Neonatorum—a Curiosity?
Christensen, Norman A.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 65 | Issue: 5 | Pages: 1149-1149

10.7326/0003-4819-65-5-1149 | PMID 5923095 Get It

Sodium Fluoride in the Treatment of Osteoporosis and Other Bone Diseases
Adams, P. H., JOWSEY, JENIFER, JOWSEY, JENIFER

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 63 | Issue: 6 | Pages: 1151-1155

10.7326/0003-4819-63-6-1151 | PMID 5320954 Get It

Perplexities in Cerebrovascular Disease
Millikan, Clark H.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 58 | Issue: 1 | Pages: 191-192

10.7326/0003-4819-58-1-191 Get It

Ciliary subcellular localization of TGR5 determines the cholangiocyte functional response to bile acid signaling
Masyuk, Anatoliy I. , Huang, Bing , Radtke, Brynn N., Gajdos, Gabriella B., Splinter, Patrick L., Masyuk, Tatyana V. , Gradilone, Sergio A. , LaRusso, Nicholas F. , Gradilone, Sergio A

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | April 12, 2013 | Volume: 304 | Issue: 11 | Pages: G1013-G1024

10.1152/ajpgi.00383.2012 | PMID 23578785 Get It

TGR5, the G protein-coupled bile acid receptor that transmits bile acid signaling into a cell functional response via the intracellular cAMP signaling pathway, is expressed in human and rodent cholangiocytes. However, detailed information on the localization and function of cholangiocyte TGR5 is limited. We demonstrated that in human (H69 cells) and rat cholangiocytes, TGR5 is localized to multiple, diverse subcellular compartments, with its strongest expression on the apical plasma, ciliary, and nuclear membranes. To evaluate the relationship between ciliary TGR5 and the cholangiocyte functional response to bile acid signaling, we used a model of ciliated and nonciliated H69 cells and demonstrated that TGR5 agonists induce opposite changes in cAMP and ERK levels in cells with and without primary cilia. The cAMP level was increased in nonciliated cholangiocytes but decreased in ciliated cells. In contrast, ERK signaling was induced in ciliated cholangiocytes but suppressed in cells without cilia. TGR5 agonists inhibited proliferation of ciliated cholangiocytes but activated proliferation of nonciliated cells. The observed differential effects of TGR5 agonists were associated with the coupling of TGR5 to Gα i protein in ciliated cells and Gα s protein in nonciliated cholangiocytes. The functional responses of nonciliated and ciliated cholangiocytes to TGR5-mediated bile acid signaling may have important pathophysiological significance in cilia-related liver disorders (i.e., cholangiociliopathies), such as polycystic liver disease. In summary, TGR5 is expressed on diverse cholangiocyte compartments, including a primary cilium, and its ciliary localization determines the cholangiocyte functional response to bile acid signaling.